Authors
Loading...
Preclinical study demonstrates that macrophage IRF5 drives liver fibrosis in mice and human disease, highlighting IRF5 inhibition as a potential therapeutic target.
Alzaïd et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: